How People Try to Beat Drug Testing and Defend Positive Results
|
By Kim Scott (AACC) Posted on 12 Jul 2022 |

Image: How People Try to Beat Drug Testing and Defend Positive Results (Photo courtesy of aacc.org)
Drug abuse is a critical problem throughout the world. While opioids are a significant public health concern, accounting for 2.88 million visits to emergency departments in the U.S. in 2016 and 2017, other drugs are also abused on a regular basis, including cocaine, amphetamines, and benzodiazepines.
In 1986, President Reagan directed federal agencies to achieve a drug-free work environment. Many private employers also employ drug testing to ensure their workplaces are safe. Approximately 20 million people are screened each year in the U.S. in workplace drug testing programs, said Amitava Dasgupta, PhD, professor of pathology and laboratory medicine at the University of Kansas Medical Center in Kansas City.
Dasgupta will discuss ways that people try to beat drug tests and strategies clinical laboratories can use to detect adulterated specimens during a roundtable session “How People Try to Beat Drug Testing and Defend Positive Results” at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo on July 24-28 in Chicago.
About 2% of people undergoing drug testing attempt to “beat” the tests, Dasgupta said. Some people try to beat drug tests by ingesting detoxifying agents designed to flush out drugs and metabolites. Others add adulterants to their urine, such as common household chemicals –laundry bleach, table salt, toilet bowl cleaner, and vinegar. While these types of adulterants are fairly easy to identify, there are chemicals that can be purchased online that are more difficult to identify in urine. In addition, some individuals purchase synthetic urine online in an attempt to beat drug tests in settings where collection of a urine specimen is not supervised.
When attempts to beat drug tests fail and a test comes back positive, individuals sometimes blame the positive result on other issues, such as eating food with poppyseeds, inhaling second-hand marijuana smoke, or taking CBD products for pain.
Dasgupta will also discuss ways to debunk common defenses of positive drug tests. “This is a very important topic because we want to have a drug-free workplace, and lab medicine professionals who are involved in the field of toxicology testing play a big role in helping ensure a safe workplace,” he said. “It’s important to know ways in which people can try to beat drug tests so you know what to look out for.”
Among the topics that will be covered during this session:
“There are 14,000 sites on the internet that tell you how to beat a drug test, Dasgupta noted. “My goal is to make sure that toxicologists know how people try to beat tests so they can be prepared in advance.”
In 1986, President Reagan directed federal agencies to achieve a drug-free work environment. Many private employers also employ drug testing to ensure their workplaces are safe. Approximately 20 million people are screened each year in the U.S. in workplace drug testing programs, said Amitava Dasgupta, PhD, professor of pathology and laboratory medicine at the University of Kansas Medical Center in Kansas City.
Dasgupta will discuss ways that people try to beat drug tests and strategies clinical laboratories can use to detect adulterated specimens during a roundtable session “How People Try to Beat Drug Testing and Defend Positive Results” at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo on July 24-28 in Chicago.
About 2% of people undergoing drug testing attempt to “beat” the tests, Dasgupta said. Some people try to beat drug tests by ingesting detoxifying agents designed to flush out drugs and metabolites. Others add adulterants to their urine, such as common household chemicals –laundry bleach, table salt, toilet bowl cleaner, and vinegar. While these types of adulterants are fairly easy to identify, there are chemicals that can be purchased online that are more difficult to identify in urine. In addition, some individuals purchase synthetic urine online in an attempt to beat drug tests in settings where collection of a urine specimen is not supervised.
When attempts to beat drug tests fail and a test comes back positive, individuals sometimes blame the positive result on other issues, such as eating food with poppyseeds, inhaling second-hand marijuana smoke, or taking CBD products for pain.
Dasgupta will also discuss ways to debunk common defenses of positive drug tests. “This is a very important topic because we want to have a drug-free workplace, and lab medicine professionals who are involved in the field of toxicology testing play a big role in helping ensure a safe workplace,” he said. “It’s important to know ways in which people can try to beat drug tests so you know what to look out for.”
Among the topics that will be covered during this session:
- What are common household chemicals that are often used to adulterate urine?
- What are commercially available products used to beat drug tests and how can you recognize when they are being used?
- How can you differentiate natural urine from synthetic urine?
- Protocols for detecting specific adulterants.
- What are common defenses for a positive drug test and how they can be debunked?
“There are 14,000 sites on the internet that tell you how to beat a drug test, Dasgupta noted. “My goal is to make sure that toxicologists know how people try to beat tests so they can be prepared in advance.”
Latest AACC 2022 News
- AACC 2022 Review: International Meetings Rebound After Suffering Long COVID Hiatus
- Faster Method Diagnoses Pediatric Urinary Tract Infections
- Tianlong Showcases Integrated PCR Lab Solutions at AACC 2022
- Cellavision Introduces New Workflow Solution for Low-Volume Hematology Labs at AACC 2022
- Advanced Instruments Introduces New Automated Osmometer at AACC 2022
- Innovative Smartphone and AI-Based Tests Featured at AACC 2022
- New Tests Presented at AACC 2022 to Solve Challenges in Children's Healthcare
- 10-Minute Sepsis Risk Stratification Test Introduced at AACC 2022
- New System Combining DNA/RNA Extraction and Smart PCR Setup Launched at AACC 2022
- Novel Small Volume Blood Collection Device Launched at AACC 2022
- AACC Disruptive Technology Award Finalists Tackle Cancer, Women's Health, and STDs
- Meridian Demonstrates State-of-the-Art Urea Breath Test System at AACC 2022
- Nikon Instruments Displays Latest Clinical Pathology Products at AACC 2022
- Seegene Showcases Latest Molecular Testing Solutions at AACC 2022
- Werfen Introduces New Acute Care Diagnostic Products for CVOR at AACC 2022
- PerkinElmer Demonstrates Vanadis NIPT Screening Platform Featuring Groundbreaking cfDNA Technology
Channels
Clinical Chemistry
view channel
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
Genomic Test Guides Chemotherapy Decisions in Early-Stage Breast Cancer
Selecting adjuvant therapy for early-stage hormone receptor-positive breast cancer depends on accurately assessing long-term risk of distant recurrence. Clinical features alone can leave uncertainty about... Read more
Simple Cytogenetic Method Could Improve Classification of ALL Subtypes
Many cancers deviate from the normal chromosome number, but the clinical impact of extreme chromosome loss remains unclear. This widespread genomic disruption is associated with aggressive disease and... Read more
Blood-Based Assay Enables Noninvasive Monitoring of Sarcoma Immunotherapy Response
Sarcomas remain difficult to monitor during immunotherapy, as low tumor mutation burden can limit traditional circulating tumor DNA approaches and repeat tissue biopsies are often impractical in advanced disease.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
Gut Microbiome Signatures Help Identify Risk of IBD Progression
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract with highly variable outcomes.... Read more
FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
Clinical guidelines support testing based on patient presentation in suspected gastrointestinal infections, yet available technologies have often forced laboratories to choose between panels that are too... Read morePathology
view channel
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read more
FDA Approval Expands Automated PD-L1 Testing Across Solid Tumors
Clinical laboratories play a central role in guiding immunotherapy by reporting programmed death ligand-1 (PD‑L1) status across multiple solid tumors. Many sites are standardizing this work on fully automated... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel









